FDA recall D-0766-2022

Aurobindo Pharma USA Inc. · Class III · drug

Product

Cyanocobalamin Injection, USP, 1,000 mcg per mL, For IM or SC Use Only, 1 mL Vial, Rx Only, Manufactured in India, for Auromedics Pharma LLC, NDC 55150-364-01.

Reason for recall

Subpotent Drug: Out of Specification results for Assay

Distribution

Nationwide in the USA.

Key facts

Status
Terminated
Initiation date
2022-04-05
Report date
2022-04-20
Termination date
2024-06-27
Voluntary/Mandated
Voluntary: Firm initiated
Location
East Windsor, NJ, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0766-2022